Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Is a New Biomarker for Mantle Cell Lymphoma: Expression, Localization, and Phosphorylation Study

Tomas Stopka, MD PhD, Jarmila Vargova, MSc, Karina Vargova, PhD, Nina Dusilkova, MD, Vojtech Kulvait, MSc, Vit Pospisil, PhD, Jiri Zavadil, PhD, Marek Trneny, Pavel Klener, MD PhD

Blood (2016) 128 (22): 1767.

https://doi.org/10.1182/blood.V128.22.1767.1767

Published: 2016

Journal Articles

Defining Criteria for Diagnosis of Occult Lymphomatous Involvement in Cerebrospinal Fluid

Heidi Mocikova, MD, PhD, Magdalena Klanova, MD, Martin Spacek, MD, PhD, Robert Pytlik, MD, PhD, Tomas Kozak, MD, PhD, Prof., Marek Trneny, MD, PhD, Prof., Vit Pospisil, PhD

Blood (2014) 124 (21): 5412.

https://doi.org/10.1182/blood.V124.21.5412.5412

Published: 2014

Journal Articles

Oncogenic Micrornas In Cerebrospinal Fluid and Sera Reflect Therapy Efficacy and Their Reappearance Precedes Clinical Relapse In Primary and Secondary CNS Lymphoma

Vit Pospisil, MSc., PhD, Heidi Mocikova, MD, PhD, Magdalena Klanova, MD, Monika Palickova, MD, Tomas Kozak, M.D., Ph.D., ass. prof., Marek Trneny, MD, Ph.D., Prof., Tomas Stopka, MD, PhD

Blood (2013) 122 (21): 1777.

https://doi.org/10.1182/blood.V122.21.1777.1777

Published: 2013

Journal Articles

Activation of Chromatin Structure Upstream PU.1 Gene and in Vitro Differentiation in High Risk Myelodysplastic Syndrome Following 5-Azacytidine,

Tomas Stopka, MD, PhD, Nikola Curik, Pavel Burda, PhD, Karin Vargova, Vit Pospisil, Petra Vlckova, Filipp Savvulidi, Emanuel Necas, Hana Hájková, Cedrik Haskovec, PhD, Monika Belickova, Jaroslav Cermak, MD, PhD, Marek Trneny, Anna Jonasova, MD

Blood (2011) 118 (21): 3791.

https://doi.org/10.1182/blood.V118.21.3791.3791

Published: 2011

Journal Articles

MicroRNA Analysis in the Cerebrospinal Fluid and Blood Serum of Lymphoma Patients At Diagnosis and in Response to Therapy,

Vit Pospisil, Heidi Mocikova, MD, PhD, Milada Jankovska, MD, Jana Markova, MD, Lubica Gaherova, MD, Tomas Kozak, MD, PhD, Tomas Stopka, MD, PhD

Blood (2011) 118 (21): 3663.

https://doi.org/10.1182/blood.V118.21.3663.3663

Published: 2011

Journal Articles

Pattern of Mir-155 and PU.1 Expression in CLL/SLL and Aggressive Lymphomas

Tomas Stopka, MD, PhD, Karin Vargova, Hana Huskova, Pavel Burda, PhD, Nikola Curik, Petra Vlckova, Vojtech Kulvait, Vit Pospisil, Filipp Savvulidi, Emanuel Necas, Marek Mraz, MD, Sarka Pospisilova, Dr, PhD, Jiri Mayer, MD, PhD, Josef Karban, Petra Obrtlikova, MD, PhD, Marek Trneny

Blood (2011) 118 (21): 4600.

https://doi.org/10.1182/blood.V118.21.4600.4600

Published: 2011

Journal Articles

Analysis of Mantle Cell Lymphoma Patients Reveals Novel Regulatory Circuits Involving MicroRNAs and Their Targets

Vojtech Kulvait, Vit Pospisil, Karin Vargova, Marek Trneny, Pavel Klener, Jr., Tomas Stopka, MD, PhD

Blood (2011) 118 (21): 4624.

https://doi.org/10.1182/blood.V118.21.4624.4624

Published: 2011

Journal Articles

MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia

Karin Vargova, Nikola Curik, Pavel Burda, Petra Basova, Vojtech Kulvait, Vit Pospisil, Filipp Savvulidi, Juraj Kokavec, Emanuel Necas, Adela Berkova, Petra Obrtlikova, Josef Karban, Marek Mraz, Sarka Pospisilova, Jiri Mayer, Marek Trneny, Jiri Zavadil, Tomas Stopka

Blood (2011) 117 (14): 3816–3825.

https://doi.org/10.1182/blood-2010-05-285064

Published: 2011

Includes: Supplemental data

Journal Articles

Active Chromatin Structure near MYB Occupancy at the Mir-155 Host Gene Promoter Coincides with Increased Mir-155 and MYB Levels In Chronic Lymphocytic Leukemia

Tomas Stopka, MD, PhD, Karin Vargova, Nikola Curik, Pavel Burda, Petra Basova, Vit Pospisil, Vojtech Kulvait, Filipp Savvulidi, Emanuel Necas, MD, PhD, Adela Berkova, MD, Petra Obrtlikova, MD, Josef Karban, MD, Marek Trneny, MD, PhD, Jiri Zavadil, PhD

Blood (2010) 116 (21): 3589.

https://doi.org/10.1182/blood.V116.21.3589.3589

Published: 2010

Journal Articles

The Oncogenic Mir-17-92 MicroRNA Cluster Is Inhibited by EGR2 During Macrophage Differentiation Via JARID1b-Mediated Histone 3 Lysine 4 Demethylation

Vit Pospisil, Karin Vargova, Juraj Kokavec, Jana Rybarova, Filipp Savvulidi, Emanuel Necas, Peter Laslo, PhD, Jiri Zavadil, PhD, Tomas Stopka, MD, PhD

Blood (2010) 116 (21): 390.

https://doi.org/10.1182/blood.V116.21.390.390

Published: 2010

Journal Articles

Transcription Factors PU.1 and EGR2 Inhibits the Oncogenic Microrna Cluster Mir-17-92 during Macrophage Differentiation

Vit Pospisil, Karin Vargova, Pavel Burda, Juraj Kokavec, Emanuel Necas, Jiri Zavadil, Tomas Stopka, MD, PhD

Blood (2008) 112 (11): 473.

https://doi.org/10.1182/blood.V112.11.473.473

Published: 2008

Journal Articles

Mutual Regulatory Loop between miR-155 and PU.1 Is a Candidate Pathogenesis Factor in CLL.

Tomas Stopka, MD, PhD, Karin Vargova, Msc., Juraj Kokavec, Msc., Vit Pospisil, Msc., Nikola Curik, Msc., Pavel Burda, Msc., Arthur I. Skoultchi, PhD., Jiri Zavadil, PhD.

Blood (2007) 110 (11): 1130.

https://doi.org/10.1182/blood.V110.11.1130.1130

Published: 2007

Journal Articles

Fog1 and Cebpa Are DNA Targets of GATA-1/PU.1 Antagonism during Leukemia Differentiation.

Pavel Burda, Msc., Nikola Curik, Msc., Juraj Kokavec, Msc., Vit Pospisil, Msc., Arthur I. Skoultchi, PhD., Jiri Zavadil, PhD., Tomas Stopka, MD, PhD

Blood (2007) 110 (11): 4121.

https://doi.org/10.1182/blood.V110.11.4121.4121

Published: 2007

Journal Articles

PU.1 Dose-Dependently Induces Granulocyte or Macrophage Commitment by Targeting Lineage Restricted Genes and by Regulating Transcription Factors Egr2, Nab2, Cebpa and Gfi1.

Vit Pospisil, Msc., Juraj Kokavec, Msc., Pavel Burda, Msc., Nikola Curik, Msc., Arthur I. Skoultchi, PhD., Jiri Zavadil, PhD., Tomas Stopka, MD, PhD

Blood (2007) 110 (11): 661.

https://doi.org/10.1182/blood.V110.11.661.661

Published: 2007

NARROW

Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Is a New Biomarker for Mantle Cell Lymphoma: Expression, Localization, and Phosphorylation Study

Defining Criteria for Diagnosis of Occult Lymphomatous Involvement in Cerebrospinal Fluid

Oncogenic Micrornas In Cerebrospinal Fluid and Sera Reflect Therapy Efficacy and Their Reappearance Precedes Clinical Relapse In Primary and Secondary CNS Lymphoma

Activation of Chromatin Structure Upstream PU.1 Gene and in Vitro Differentiation in High Risk Myelodysplastic Syndrome Following 5-Azacytidine,

MicroRNA Analysis in the Cerebrospinal Fluid and Blood Serum of Lymphoma Patients At Diagnosis and in Response to Therapy,

Pattern of Mir-155 and PU.1 Expression in CLL/SLL and Aggressive Lymphomas

Analysis of Mantle Cell Lymphoma Patients Reveals Novel Regulatory Circuits Involving MicroRNAs and Their Targets

MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia

Active Chromatin Structure near MYB Occupancy at the Mir-155 Host Gene Promoter Coincides with Increased Mir-155 and MYB Levels In Chronic Lymphocytic Leukemia

The Oncogenic Mir-17-92 MicroRNA Cluster Is Inhibited by EGR2 During Macrophage Differentiation Via JARID1b-Mediated Histone 3 Lysine 4 Demethylation

Transcription Factors PU.1 and EGR2 Inhibits the Oncogenic Microrna Cluster Mir-17-92 during Macrophage Differentiation

Mutual Regulatory Loop between miR-155 and PU.1 Is a Candidate Pathogenesis Factor in CLL.

Fog1 and Cebpa Are DNA Targets of GATA-1/PU.1 Antagonism during Leukemia Differentiation.

PU.1 Dose-Dependently Induces Granulocyte or Macrophage Commitment by Targeting Lineage Restricted Genes and by Regulating Transcription Factors Egr2, Nab2, Cebpa and Gfi1.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only